doi: 10.1161/01.CIR.0000139386.21421.a2
(Circulation. 2004;110:e39.)
© 2004 American Heart Association, Inc.
Correspondence |
Cardiovascular Protections in Severely Impaired Hemostasis
Cardiology Service, Casa di Cura "Città di Udine", Udine, Italy
Cardiology Service, Ospedale di Tolmezzo, Tolmezzo, Italy
To the Editor:
There is mounting evidence that severely impaired hemostasis is associated with a decreased risk of ischemic cardiovascular disease. In a study with long follow-up, hemophilic patients had an 80% reduction in the risk of fatal ischemic heart disease.1 In clinical practice, occurrence of cardiovascular disease is uncommon in patients with type 3 severe von Willebrand disease, a coagulation disorder in which the severity of bleeding may sometimes resemble that in patients with hemophilia.
However, 
rámek et al2 reported that patients with type 3 von Willebrand disease were not protected against the development of early atherosclerosis changes as assessed by measuring carotid and femoral intima-media thickness, thus suggesting that von Willebrand factor is not essential for the development of atherosclerosis. Therefore, in impaired hemostasis, other cardiovascular protective mechanisms could be involved.
An epidemiological study3 found that serum ferritin, a good measurement of body iron stores, emerged as one of the strongest risk factors for progression of carotid atherosclerosis. Furthermore, a recent study4 identified an independent relationship between serum ferritin levels and carotid atherosclerosis. Although ferritin levels have not been shown to be associated with carotid intima-media thickness,4,5 body iron stores may promote atherosclerosis at a stage beyond intima-media thickening. Thus, the protection against ischemic cardiovascular disease in individuals with impaired hemostasis might be related to the decrease of stored tissue iron caused by recurrent bleeding.
References
1. Triemstra M, Rosendaal FR, Smit C, et al. Mortality in patients with hemophilia: changes in a Dutch population from 1986 to 1992 and 1973 to 1986. Ann Intern Med. 1995; 123: 823–827.
2. rámek A, Bucciarelli P, Federici AB, et al. Patients with 3 severe von Willebrand disease are not protected against atherosclerosis: results from a multicenter study in 47 patients. Circulation. 2004; 109: 740–744.
3. Kiechl S, Willeit J, Egger G, et al. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation. 1997; 96: 3300–3307.
4. Wolff B, Völzke H, Lüdemann J, et al. Association between high serum ferritin levels and carotid atherosclerosis in the Study of Health In Pomerania (SHIP). Stroke. 2004; 35: 453–457.
5. Moore M, Folsom AR, Barnes RW, et al. No association between serum ferritin and asymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 1995; 141: 719–723.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||